Navigation Links
Decision Resources Group Announces First Medical Device Account Targeting Tool in China
Date:7/31/2014

BURLINGTON, Mass., July 31, 2014 /PRNewswire/ -- Decision Resources Group is launching an extension of its premier medical technology market intelligence product Marketrack to now include ChinaTrack; the new capabilities track the China device landscape in an interactive dashboard providing detailed brand-level share tracking and analytics. ChinaTrack also provides detailed procedure volumes at a hospital level.

Other key capabilities of the new line extension:

  • Updated data feed: In addition to end-user surveys of healthcare facilities, ChinaTrack data is paired with a database of procedure volumes for Tier 3 hospitals in China.
  • Online interactive dashboard: Full data and analysis is accessible in an interactive platform, with regular updates delivered shortly after the reporting period.
  • Key market coverage: Decision Resources Group offers coverage of the most active segments of the Chinese device markets, including:
    • Cardiac rhythm management and surgery
    • Electrophysiology
    • Ostomy
    • Vertebral compression fracture treatments
    • Heart valves

Comments from Decision Resources Group Director of Brand Solutions Jennifer Thomas:

  • "Across the China medical device industry, there is a strong unmet need for detailed market landscape information. ChinaTrack showcases the number of procedures by Tier 3 facility name to help our clients effectively strategize sales efforts in region. To provide such thorough procedure tracking at the hospital level for these Tier 3 facilities in China is completely novel."
  • "For a truly comprehensive view of the Chinese market, our expert analysts are now able to bring together usage data from end-user surveys and pair it with detailed facility-level procedures, published on an online interactive dashboard. We are thrilled to be the first provider of this type of competitive intelligence in China.

About Marketrack
Marketrack provides ongoing brand-level market share data from facilities in 40 countries and 20 medtech markets around the world, updated monthly or quarterly within 15 days following the reporting period. Each Marketrack ready-to-use deliverable provides a comprehensive and detailed view of a market of interest, including data on procedures, units used and average selling prices across a given device category.

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group 
Christopher Comfort 
781-993-2597  
ccomfort@dresourcesgroup.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO


'/>"/>
SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement
2. Digital Resources Play Critical Role in Formulary Decision Making
3. Fattah Applauds Walgreens Decision to Cover Month of Medications for ACA Enrollees
4. Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Medical Mutual
5. Decision Resources to Publish Reports That Include Market Analysis and a Forecast through 2022 for the Hepatitis C Virus and Hospital-Treated Bacterial Infections Drug Markets
6. National Decision Support Company offers free access to ACR Select
7. Pharmspective Launches Affordable Care Act eLearning for Healthcare Decision-Makers
8. Pharmaceutical Industry Turning to Emerging Market Research Tools to Better Understand Consumer Decision-Making
9. Decision on State Exchanges Will Aid Patient Access to Medications
10. Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Humana, Inc.
11. Beyond the Headlines: What the FDA Decisions on Extended-release and Long-Acting Opioids Mean for People With Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Following receiving CE Marking in Europe ... AMAR is a major milestone for the country where the device was developed ... market in Israel   ... inclusion in the National Health Basket , Israel , ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced wound ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... their offering. ... research Dry eye Drugs Price Analysis and Strategies - 2016, provides drug ... research answers the following questions: What are ... are they positioned in the Global Dry eye market? ...
(Date:2/24/2017)... Feb. 23, 2017 The U.S. Food ... PhenoTest BC Kit, performed on the Pheno System. ... that cause bloodstream infections and provide information about ... to (antibiotic sensitivity). The test also reduces the ... important information, which can guide antibiotic treatment recommendations ...
Breaking Medicine Technology:
(Date:2/24/2017)... , ... February 24, 2017 , ... The Smart Machine ... from Oxford University predict that 47 percent of all jobs in the United States ... “smart” and “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users now ... . Users have total control over position, rotation, distortion, edge softness, edge blur, chromatic ... Cut Pro X. , With ProGlass Prism users are given the tools and ...
(Date:2/24/2017)... Farifax, VA (PRWEB) , ... February 24, 2017 , ... ... winners for excellence in radiology marketing programs at the annual Building Better ... the Worthington Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given ...
(Date:2/23/2017)... MA (PRWEB) , ... February 23, 2017 , ... ... and Department of Justice jointly issued a letter to withdraw previous ... accordance with their gender identity. The guidance issued in May 2016 by the ...
(Date:2/23/2017)... ... 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will ... to Hot,” which will begin airing on February 24, 2017. The show chronicles the ... 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC ...
Breaking Medicine News(10 mins):